David & Goliath: Small Biotechs Wage a Big Fight Against the Superbug

By Valorie Sands  APR 01, 2013 11:45 AM

Despite amazing strides in many areas of medical technology, Big Pharma lags small caps in the fight against the antibiotic-resistant superbug MRSA.

 


No positions in stocks mentioned.